We would love to hear your thoughts about our site and services, please take our survey here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGlaxosmithkline Share News (GSK)

Share Price Information for Glaxosmithkline (GSK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,700.00
Bid: 1,699.50
Ask: 1,700.00
Change: -5.00 (-0.29%)
Spread: 0.50 (0.029%)
Open: 1,705.00
High: 1,711.00
Low: 1,695.50
Prev. Close: 1,705.00
GSK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

MARKET PULSE-Primus telecommunications, Verizon, Morgan Stanley

Thu, 18th Apr 2013 18:09

(For more market insights, including options activity, click on ; for the Day Ahead newsletter http://link.reuters.com/mex49s; for the Morning News Call newsletter, http://link.reuters.com/faq23t)

April 18 (Reuters) - Some U.S. stocks on the move onThursday:

WALL ST SLIDES FURTHER, UPTREND IN PERIL

Stocks fell after data showed signs of slower growth aheadfor the U.S. economy, with traders zoning in on technicals toanticipate the market's next move. The Dow Jones industrialaverage fell 52.19 points or 0.36 percent, to 14,566.40,the S&P 500 lost 6.82 points or 0.44 percent, to 1,545.19and the Nasdaq Composite dropped 26.03 points or 0.81percent, to 3,178.64.

** VERIZON COMMUNICATIONS INC, $51.28, up 3.5 pct(1339 ET)

The telephone company reported a higher-than-expectedfirst-quarter profit, driven by strength in its wirelessbusiness.

** MORGAN STANLEY, $20.51, down 4.5 pct (1339 ET)

The sixth-largest U.S. bank by assets said revenue fromcommodities trading fell sharply in the first quarter and it wasworking to dispose of nonessential commodity businesses.

** OVERSTOCK.COM INC, $15.23, up 33 pct (1357 ET)

The discount e-retailer reported a 19 percent jump inrevenue helped by higher average order size. Gross profit in thequarter also improved due to a shift to higher margin home andgarden products, and lower warehousing costs, in turn boostingprofit.

** PRIMUS TELECOMMUNICATIONS GROUP INC, $12.25, up24 pct (1209 ET)

The advanced communication solutions provider said onWednesday it sold its data center operations in Canada,Blackiron Data ULC, to Rogers Communications Inc for about C$200million ($195.15 million).

Primus provides domestic and international long-distance,Internet service, and Voice over Internet Protocol (VOIP). Thestock, trading nearly ten times its average 10-day volume, wasthe top percentage gainer on the New York Stock Exchange at 1209ET.

** SINOVAC BIOTECH LTD, $3.79, down 8.2 pct (1357ET)

The pharmaceutical company said fourth-quarter revenue fellto $19 million, from $21.1 million a year ago, as the companyrecorded no sales of its H1N1 flu vaccine in the quarter endedDec. 31.

** NORTHWEST BIOTHERAPEUTICS INC, $3.76, down 3.6pct (1356 ET)

The company entered into an agreement with ahealthcare-dedicated institutional investor for a registereddirect placement of $10 million of its common stock. Northwestalso said it will issue warrant coverage of 40 percent to theinvestor to buy shares of common stock at an exercise price of$4.29 per share.

** PEABODY ENERGY CORP, $20.57, up 8 pct (1356 ET)

** ARCH COAL INC, $5.04, up 11 pct (1404 ET)

The world's largest private sector coal miner reported asmaller-than-expected first-quarter loss on Thursday as itpushed to cut costs in a tough market, but revenue fell justshort of analysts' expectations.

Shares of peer Arch Coal were also up on the news.

** TAMINCO CORP, $14.25 (1215 ET)

The company's shares fell as much as 8 percent in theirtrading debut, valuing the company at nearly $900 million, wellbelow the price Apollo Global Management LLC paid toacquire the chemical maker from CVC Capital Partners in 2011.

** PEPSICO INC, $81.66, up 4 pct (1356 ET)

The maker of Pepsi sodas, Tropicana juices, Frito-Lay snacksand Quaker oatmeal reported better-than-expected first-quarterearnings, as price increases helped margins.

** GREENHILL & CO INC, $46.20, down 10 percent (1355ET)

The boutique investment bank reported first-quarter resultson Wednesday that widely missed estimates due to an investmentloss of $1.9 million compared to an investment gain of $9.4million in the year-earlier quarter.

At least four brokerages cut their price target on thecompany' stock.

** EAST WEST BANCORP, $23.08, down 4 pt (1354 ET)

The bank reported quarterly results on Wednesday that beatestimates, but net interest margin declined due to reducednon-covered loan portfolio yields.

BMO Capital Markets cut its rating on the company's stockto "market perform" from "outperform," while Sterne Ageedowngraded it to "neutral" from "buy" and lowered its pricetarget to $25 from $26.

** ESCO TECHNOLOGIES INC, $35.54, down 5.3 pct (1219ET)

Brokerage Oppenheimer & Co downgraded the engineeredproducts maker to "perform," saying project delays in the USwater market and fewer COOP deliveries lower Esco's near-termoutlook.

Wedbush Securities cut its target price to $48 from $50.

** SELECT COMFORT CORP, $18.04, up 3 pct (1357 ET)

Specialty mattress maker Select Comfort said it would revertto its earlier marketing strategy after a shift in advertisingreduced exposure of its products to already cautious customersand hit sales.

"While management clearly took their eye off the ball on themarketing, they are aggressively working to rectify thesituation and are seeing improvements in the business as aresult," Joan Storms of Wedbush Securities wrote in a note.

** UNIVERSAL FOREST PRODUCTS INC, $37.03, up 8.6pct (1353 ET)

The maker of wood and wood-alternative products reported itsfirst-quarter profit that beat analysts' estimates withincreased sales in each of its units due to 42.9 percentincrease in the lumber market.

** J.C. PENNEY, $15.03, up 1.7 pct (1259 ET)

** MACYS INC, $43.12, down 1.2 pct (1259 ET)

New York appeals court judge, Justice Richard Andrias, ruledthat J.C. Penney could sell Martha Stewart goods under a "JCPEveryday" label for now, pending an appeal by Macy's.

** COINSTAR INC, $54.47, down 3.5 (1353 ET)

Brokerage ITG Research lowered its revenue estimates for theoperator of Redbox video rental kiosks, citing weak March salestrends, the flyonthewall.com reported.

** DANAHER CORP, $58.22, down 2.5 pct (1353 ET)

The industrial and healthcare conglomerate's first-quarterprofit missed analysts' estimates as operating margin at itslargest business, life sciences & diagnostics, fell about 60basis points. The company also forecast second-quarter earningsbelow analysts' estimates.

** CORE LABORATORIES NV, $137.44, up 9 pct (1351 ET)

The oilfield services company reported its first-quarterprofit on Wednesday that topped analysts' expectations, asrevenue from its production enhancement operations, which dealswith increasing oilfield recovery factor, rose 11 percent.

** NOBLE CORP, $36.26, up 4 pct (1351 ET)

The owner of the world's third-largest offshore drillingfleet said Royal Dutch Shell Plc was in talks to extendits contract to use the Noble Discoverer beyond February 2014,underlining its long-term plans for the offshore Arctic.

GOLD STOCKS

** RANDGOLD RESOURCES LTD, $70.78, up 6 pct (1351ET)

** NEWMONT MINING CORP, $32.76, up 1.3 pct (1351 ET)

** ANGLOGOLD ASHANTI LTD, $17.90, up 2 pct (1351 ET)

** BARRICK GOLD CORP , $17.78, up 1 pct(1351 ET)

** FIRST MAJESTIC SILVER INC, $11.62, up 6 pct (1351ET)

** YAMANA GOLD INC, $11.53, up 4 pct (1351 ET)

** KINROSS GOLD CORP, $5.30, up 6 pct (1351 ET)

Gold rallied on Thursday in Europe after volatile Asiantrade saw prices slide towards two-year lows hit earlier in theweek, with strong physical buying set against exits fromexchange-traded funds. The sharp drop in prices has triggered aspate of buying in gold bars, coins and nuggets in Asia, whileU.S. gold coins have flown off dealers' shelves.

** EXACT SCIENCES CORP, $7.95, down 20.2 pct (1348ET)

The company said its molecular screening test for colorectalcancer met its goals in a large late-stage study, detecting thedisease in more than 90 percent of patients, but its sharesplummeted as much as 30 percent as the results were not asrobust as some were expecting.

** TRAVELZOO INC, $24.30, up 12 pct (1348 ET)

The online travel deals company reported a 7 percent rise infirst-quarter revenue, with its Europe travel business growing14 percent.

** THERAVANCE INC, $32.07, up 14.5 pct (1348 ET)

An advisory panel to the U.S. Food and Drug Administrationhas recommended that the agency approve an experimentaltreatment for smoking-related lung damage made by Britain'sGlaxoSmithKline Plc and Theravance.

** NOKIA OYJ , $3.17, down 11.5 pct (1316ET)

A big fall in sales of the company's basic phonesovershadowed a stronger performance from its Lumia smartphonesin the first quarter, and it said it expected operating marginsto deteriorate.

Chief Executive Stephen Elop said tougher competition wasthe main reason behind the fall in sales of regular mobilephones.

** PHILIP MORRIS INTERNATIONAL INC, $91.67, down 2.5pct (1347 ET)

The company, which sells Marlboro, reported first-quarterprofit that missed estimates as cigarette shipment volumesdeclined 6.5 percent.

** ULTRATECH INC, $31.70, down 13 pct (1405 ET)

The company, which manufactures chip-making equipment,reported lower-than-expected quarterly results.

** PRIVATEBANCORP INC, $18.80, up 8 pct (1347 ET)

The lender reported higher-than-expected quarterly profit,helped by mortgage banking and syndication fee revenue.Non-interest income rose 11 percent to $30.5 million.

** UNIPIXEL INC, $33.24, down 12.7 pct (1346 ET)

The LCD film maker said its offering of 1.2 million shareswas priced at $32 per share, a 16 percent discount to thestock's closing price on Wednesday.

** PPG INDUSTRIES INC, $140.16, up 6 pct (1345 ET)

The protective and decorative coatings maker reported aquarterly profit that beat analysts' estimates, helped by astrong demand in North America and Asia, and said it expects thepositive momentum in these geographies to continue in the secondquarter.

PPG also approved its quarterly dividend to 61 cents pershare from 59 cents per share.

** UNION PACIFIC CORP, $142.91, up 4.3 pct (1345 ET)

The No.1 U.S. railroad reported a strong first quarter ashigher freight rates offset a decline in coal shipments, and thecompany said it expects to ship more of the commodity in thecurrent quarter.

HEALTH INSURER STOCKS

** UNITEDHEALTH GROUP INC, $60.05, down 3 pct (1344ET)

** HUMANA INC, $72.49, down 3 pct (1344 ET)

** AETNA INC, $54.52, down 1.4 pct (1344 ET)

** WELLCARE HEALTH PLANS INC, $57.53, down 3 pct(1344 ET)

** MOLINA HEALTHCARE INC, $32.89, down 1 pct (1344ET)

** UNIVERSAL AMERICAN CORP, $8.78, down 2.2 pct(1344 ET)

** CENTENE CORP, $44.52, down 1.3 pct (1344 ET)

** WELLPOINT INC, $67.67, down 2 pct (1344 ET)

Shares of U.S. health insurers were down, a day after thelargest U.S. health insurer UnitedHealth reported bleakfirst-quarter profit due to lower government payments for itsprivate Medicare services and prescription plans for olderAmericans, and cut its 2013 revenue expectation.

** ALLISON TRANSMISSION HOLDINGS INC, $21.94, up3.7 pct (1341 ET)

The maker of fully-automatic transmissions said late onWednesday that investment funds affiliated with Carlyle Group LP and Onex Corp would not proceed with a secondaryoffering of Allison Transmission's common stock due to marketconditions.

** EBAY INC, $52.97, down 5.6 pct (1341 ET)

The e-commerce company gave a disappointing earningsforecast for the second quarter and said Europe was weak,pushing its shares lower in after-hours trade. (Compiled by Aditi Shrivastava; Editing by Joyjeet Das)

More News
21 Nov 2023 11:52

GSK to begin phase 3 trials of low-carbon Ventolin inhaler in 2024

(Alliance News) - GSK PLC on Tuesday said it will begin phase 3 trials of a low carbon version of its metered dose inhaler Ventolin using a "next generation" propellant in 2024.

Read more
14 Nov 2023 17:04

LONDON MARKET CLOSE: FTSE 100 underwhelms as stocks jump after US CPI

(Alliance News) - European equities jumped in the wake of a cooler-than-expected US inflation reading, which took some sting out of a recent hawkish reassessment of the Federal Reserve interest rate outlook.

Read more
13 Nov 2023 09:47

GSK hails momelotinib opinion from European Medicines Agency committee

(Alliance News) - GSK PLC on Monday announced that a European Medicines Agency panel has given a positive opinion recommending momelotinib to treat myelofibrosis patients with anaemia.

Read more
9 Nov 2023 15:50

UK dividends calendar - next 7 days

Friday 10 November 
Bodycote PLCdividend payment date
Breedon Group PLCdividend payment date
Chesnara PLCdividend payment date
Finsbury Growth & Income Trust PLCdividend payment date
Invesco Bond Income Plus Ltddividend payment date
JPMorgan Emerging Markets Investment Trust PLCdividend payment date
Kerry Group PLCdividend payment date
Merchants Trust PLCdividend payment date
Mid Wynd International Investment Trust PLCdividend payment date
Mid Wynd International Investment Trust PLCspecial dividend payment date
Montanaro UK Smaller Cos Investment Trust PLCdividend payment date
Senior PLCdividend payment date
Spectris PLCdividend payment date
Spirax-Sarco Engineering PLCdividend payment date
Travis Perkins PLCdividend payment date
Monday 13 November 
no events scheduled 
Tuesday 14 November 
no events scheduled 
Wednesday 15 November 
Coats Group PLCdividend payment date
Ferguson PLCdividend payment date
JP Morgan Mid Cap Investment Trust PLCdividend payment date
Strategic Equity Capital PLCdividend payment date
Thursday 16 November 
abrdn Property Income Trust Ltdex-dividend payment date
Asian Energy Impact Trust PLCex-dividend payment date
Baillie Gifford Japan Trust PLCex-dividend payment date
BlackRock Greater Europe Investment Trust PLCex-dividend payment date
Bunzl PLCex-dividend payment date
Bytes Technology Group PLCex-dividend payment date
Centrica PLCdividend payment date
Coca-Cola Europacific Partners PLCex-dividend payment date
DX Group PLCex-dividend payment date
Empiric Student Property PLCex-dividend payment date
Fonix Mobile PLCex-dividend payment date
GCP Asset Backed Income Fund Ltdex-dividend payment date
GSK PLCex-dividend payment date
Hargreaves Lansdown PLCex-dividend payment date
Henderson Opportunities Trust PLCex-dividend payment date
ICG Enterprise Trust PLCex-dividend payment date
James Halstead PLCex-dividend payment date
Lancashire Holdings Ltdspecial ex-dividend payment date
Majedie Investments PLCex-dividend payment date
Marks & Spencer Group PLCex-dividend payment date
Murray Income Trust PLCex-dividend payment date
New Star Investment Trust PLCex-dividend payment date
NextEnergy Solar Fund Ltdex-dividend payment date
Octopus Renewables Infrastructure Trust PLCex-dividend payment date
Pershing Square Holdings Ltdex-dividend payment date
Personal Group Holdings PLCdividend payment date
Redrow PLCdividend payment date
Regional REIT Ltdex-dividend payment date
Schroder Oriental Income Fund Ltdex-dividend payment date
Scottish American Investment Co PLCex-dividend payment date
SCS Group PLCex-dividend payment date
Shell PLCex-dividend payment date
Supermarket Income REIT PLCdividend payment date
UK Commercial Property REIT Ltdex-dividend payment date
Unilever PLCex-dividend payment date
Wincanton PLCex-dividend payment date
  
Copyright 2023 Alliance News Ltd. All Rights Reserved.

Read more
8 Nov 2023 09:30

LONDON BROKER RATINGS: UBS downbeat on AJ Bell and Hargreaves Lansdown

(Alliance News) - The following London-listed shares received analyst recommendations Wednesday morning and Tuesday:

Read more
2 Nov 2023 10:14

LONDON BROKER RATINGS: Bank of America starts Unite Group with 'buy'

(Alliance News) - The following London-listed shares received analyst recommendations Thursday morning and Wednesday:

Read more
1 Nov 2023 16:52

LONDON MARKET CLOSE: Stocks prosper ahead of central bank rate calls

(Alliance News) - Stocks in London took their lead from a positive start on Wall Street to close higher as investors prepare for interest rate decisions in the UK and US.

Read more
1 Nov 2023 16:35

London close: Stocks rise ahead of US Fed policy decision

(Sharecast News) - London's stock market finished in positive territory on Wednesday, with investors keeping a keen eye on the upcoming policy announcement from the US Federal Reserve.

Read more
1 Nov 2023 08:51

TOP NEWS: GSK ups guidance as boosted by Shingrix and Arexvy

(Alliance News) - GSK PLC on Wednesday hailed the performance of the world's first approved respiratory syncytial virus vaccine Arexvy, as it reported a rise in profit and revenue.

Read more
1 Nov 2023 08:50

LONDON MARKET OPEN: FTSE 100 up, FTSE 250 down as Aston Martin tumbles

(Alliance News) - Stock prices in London opened mixed on Wednesday, ahead of key central bank decisions, as investors were cheered by some strong updates from large-cap listings.

Read more
1 Nov 2023 07:40

LONDON BRIEFING: GSK raises annual guidance following Arexvy launch

(Alliance News) - Stocks in London are called higher on Wednesday, with the main focal point for the day being the upcoming US interest rate decision.

Read more
1 Nov 2023 07:27

GSK hikes guidance after strong third quarter

(Sharecast News) - GSK announced a robust third quarter on Wednesday, prompting an upgrade to its full-year guidance.

Read more
30 Oct 2023 09:01

IN BRIEF: GSK says Jemperli meets endpoint in endometrial cancer trial

GSK PLC - Brentford, west London-based pharmaceutical maker - Jemperli, whose generic name is dostarlimab, meets endpoint of overall survival in phase III Ruby trial on adult patients with primary advanced or recurrent endometrial cancer. Jemperli, combined with standard-of-care chemotherapy, followed by dostarlimab, demonstrated a "statistically significant and clinically meaningful benefit" to the patients in the trial.

Read more
30 Oct 2023 07:06

GSK's Jemperli sees success in endometrial cancer trial

(Sharecast News) - GSK reported encouraging outcomes from part one of the 'RUBY' phase three trial evaluating the efficacy of 'Jemperli', or dostarlimab, with standard chemotherapy for treating adult patients with advanced or recurrent endometrial cancer on Monday.

Read more
26 Oct 2023 09:19

TOP NEWS: GSK subsidiary ViiV receives HIV drug approval in China

(Alliance News) - GSK PLC on Thursday said its subsidiary ViiV Healthcare has received marketing authorisation in China for its cabotegravir treatment, marketed as Vocabria.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.